Heart defibrillator company signs decree

May 01, 2008

The U.S. Food and Drug Administration said Medtronic Inc. has agreed to comply with FDA rules in manufacturing its external heart defibrillators.

The FDA said Medtronic, its Physio-Control Inc. subsidiary and two high-ranking executives signed a consent decree calling for a permanent injunction involving the company's automatic external defibrillators manufactured by Physio-Control.

"The consent decree prohibits the manufacture, distribution and export of specified AEDs at or from Physio-Control's facility in Redmond, Wash., until the devices and facilities have been shown to be in compliance with the Food and Drug Administration's current 'Good Manufacturing Practice' requirements, as set forth in the … regulation for devices," the FDA said in a statement.

AEDs are portable devices used to restore normal heart rhythm to people who suffer heart attacks that produce ventricular fibrillation. The AEDs deliver an electric shock that stuns the heart for a moment, giving it the chance to resume beating effectively.

FDA inspections revealed deficiencies in the manufacturing process. Although those deficiencies don't necessarily mean that the defibrillators on the market will harm patients, the FDA said it is requiring corrections to "ensure the continued availability of safe, effective and reliable products."

Copyright 2008 by United Press International

Explore further: Suboptimal prescribing attitudes could signal personal distress

Related Stories

Device extracts rare tumor cells using sound

Apr 06, 2015

A simple blood test may one day replace invasive biopsies thanks to a new device that uses sound waves to separate blood-borne cancer cells from white blood cells.

Straight to the heart

Aug 18, 2014

A battery-less, wirelessly-powered implantable defibrillator for atrial fibrillation is being developed by an international team of researchers in the UK, Venezuela and the US. With the ability to sense the ...

Recommended for you

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.